Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Epoetin zeta 40,000units/1ml inj pre-filled syringes
0901030Q0AAAIAI
|
Epoetin zeta | Epoetin zeta | Nutrition and Blood | No data available |
|
Epoetin zeta 5,000units/0.5ml inj pre-filled syringes
0901030Q0AAAEAE
|
Epoetin zeta | Epoetin zeta | Nutrition and Blood | No data available |
|
Epoprostenol 1.5mg (pH10.5) inf vials
0208010E0AAABAB
|
Epoprostenol sodium | Epoprostenol sodium | Cardiovascular System | No data available |
|
Epoprostenol 1.5mg pdr & solv inf vials
0208010E0AAAEAE
|
Epoprostenol sodium | Epoprostenol sodium | Cardiovascular System | No data available |
|
Epoprostenol 1.5mg pdr for soln (pH12) inf vials
0208010E0AAADAD
|
Epoprostenol sodium | Epoprostenol sodium | Cardiovascular System | No data available |
|
Epoprostenol 500microgram (pH10.5) inf vials
0208010E0AAAAAA
|
Epoprostenol sodium | Epoprostenol sodium | Cardiovascular System | No data available |
|
Epoprostenol 500microgram pdr & solv inf vials
0208010E0AAAFAF
|
Epoprostenol sodium | Epoprostenol sodium | Cardiovascular System | No data available |
|
Epoprostenol 500microgram pdr for soln (pH12) inf vials
0208010E0AAACAC
|
Epoprostenol sodium | Epoprostenol sodium | Cardiovascular System | No data available |
|
Eporatio 1,000units/0.5ml inj pre-filled syringes
0901030S0BBAAAA
|
Eporatio | Epoetin theta | Nutrition and Blood | No data available |
|
Eporatio 10,000units/1ml inj pre-filled syringes
0901030S0BBAFAF
|
Eporatio | Epoetin theta | Nutrition and Blood | No data available |
|
Eporatio 2,000units/0.5ml inj pre-filled syringes
0901030S0BBABAB
|
Eporatio | Epoetin theta | Nutrition and Blood | No data available |
|
Eporatio 20,000units/1ml inj pre-filled syringes
0901030S0BBAGAG
|
Eporatio | Epoetin theta | Nutrition and Blood | No data available |
|
Eporatio 3,000units/0.5ml inj pre-filled syringes
0901030S0BBACAC
|
Eporatio | Epoetin theta | Nutrition and Blood | No data available |
|
Eporatio 30,000units/1ml inj pre-filled syringes
0901030S0BBAHAH
|
Eporatio | Epoetin theta | Nutrition and Blood | No data available |
|
Eporatio 4,000units/0.5ml inj pre-filled syringes
0901030S0BBADAD
|
Eporatio | Epoetin theta | Nutrition and Blood | No data available |
|
Eporatio 5,000units/0.5ml inj pre-filled syringes
0901030S0BBAEAE
|
Eporatio | Epoetin theta | Nutrition and Blood | No data available |
|
Eposin 100mg/5ml concentrate for solution for infusion vials
0801040D0BCAAAD
|
Eposin | Etoposide | Malignant Disease and Immunosuppression | No data available |
|
Eposin 500mg/25ml concentrate for inf vials
0801040D0BCABAF
|
Eposin | Etoposide | Malignant Disease and Immunosuppression | No data available |
|
Eppy 1% eye drops
1106000F0BBAAAD
|
Eppy | Adrenaline | Eye | No data available |
|
Eprex 1,000units/0.5ml inj pre-filled syringes
0901030D0BBAHAH
|
Eprex | Epoetin alfa | Nutrition and Blood | No data available |
|
Eprex 40,000units/1ml solution for injection vials
0901030D0BBASAS
|
Eprex | Epoetin alfa | Nutrition and Blood | No data available |
|
Eprex 7,000units/0.7ml inj pre-filled syringes
0901030D0BBAPAP
|
Eprex | Epoetin alfa | Nutrition and Blood | No data available |
|
Eprex 9,000units/0.9ml inj pre-filled syringes
0901030D0BBARAR
|
Eprex | Epoetin alfa | Nutrition and Blood | No data available |
|
Eprosartan 300mg/5ml oral liquid
0205052W0AAADAD
|
Eprosartan | Eprosartan | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 120,000unit inj vials
0211000Z0AAABAB
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.